The Effect of Thiamine, Ascorbic Acid, and the Combination of Them on the Levels of Matrix Metalloproteinase-9 in Sepsis Patients
Background: Sepsis is a global health problem. Therapeutic agents continue to develop for the management of sepsis. Ascorbic acid and thiamine are currently potential agents intensively studied for their benefits in sepsis. Methods: This study was a randomized controlled trial (RCT) with a pretest-p...
Gespeichert in:
Veröffentlicht in: | Infection and drug resistance 2022-10, Vol.15, p.5741 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | 5741 |
container_title | Infection and drug resistance |
container_volume | 15 |
creator | Lubis, Bastian Lelo, Aznan Amelia, Putri Prima, Agus |
description | Background: Sepsis is a global health problem. Therapeutic agents continue to develop for the management of sepsis. Ascorbic acid and thiamine are currently potential agents intensively studied for their benefits in sepsis. Methods: This study was a randomized controlled trial (RCT) with a pretest-posttest control group design. Randomization was using a computer. The research was conducted at Haji Adam Malik General Hospital Medan and Grand Medistra Hospital. Blood tests were at the Integrated Laboratory of the Faculty of Medicine, University of North Sumatra. The research was for 14 months. The number of patients in this study was 86 septic patients divided into four groups (NaCl, thiamine, ascorbic acid, and combination). The parameters measured were the enzyme MMP-9 and the enzyme TIMP-1. Results: The number of subjects who met the inclusion criteria was 147 patients. Fifty-three patients passed away during the monitoring period, and eight blood samples were damaged. The final data analyzed consisted of 86 subjects. Of the 86 septic patients obtained Based on initial MMP-9 values, MMP-9 levels increased in the 0.9% NaCl group (25.6%), while MMP-9 levels decreased after intervention in the thiamine, ascorbic acid, and combination groups but a significant decrease in MMP-9 was found in the ascorbic acid group (17.2%; p = 0.04) and the combination group (17.9%; p = 0.026). For TIMP-1 levels, a decreasing trend was only in the ascorbic acid (5.1%) and combination (5.9%) but not significant (p > 0.05). The highest MMP-9/TIMP-1 ratio was in septic patients receiving thiamine with a significant linear correlation (p < 0.05) between levels of MMP-9 and the MMP-9/TIMP-1 ratio with a moderate correlation level and significant negative correlation (p < 0.05) between TIMP-1 and the MMP-9/TIMP-1 with a moderate level of correlation. Conclusion: Administration of thiamine alone gives better advantages than ascorbic acid alone and their combination. Keywords: sepsis, MMP-9, TIMP-1, MMP-9/TIMP-1 ratio, thiamine, ascorbic acid |
doi_str_mv | 10.2147/IDR.S378523 |
format | Article |
fullrecord | <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A727878424</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A727878424</galeid><sourcerecordid>A727878424</sourcerecordid><originalsourceid>FETCH-LOGICAL-g674-6388921a557f08989d7652c6b5fb5f767d7828e509ce3f6a1c192b2b5bd0a98c3</originalsourceid><addsrcrecordid>eNptjE9Lw0AQxRdRsNSe_AILXpuYbJL9cwy1aqFFsbmXzWa2XUl2S3YRr35zt9RDD84MzOPN7w1C93mWkrxkj6unj3RbMF6R4gpN8pzxhApWXF_oWzTz_jOLVQhaMjJBP80B8FJrUAE7jZuDkYOxMMe1V25sjcK1Mt0cS9vhENGFG1pjZTDOnnkYcJSn0xq-oPcndyPDaL7xBoLse3ccXYCY8ZAIbCzewtEbj9_jE7DB36EbLXsPs789Rc3zslm8Juu3l9WiXid7ysqEFpwLksuqYjrjgouO0Yoo2lY6DqOsY5xwqDKhoNBU5ioXpCVt1XaZFFwVU_RwfruXPeyM1S6MUg3Gq13NCOOMl6SMVPoPFbuDwShnQZvoXwR-Adskb_s</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The Effect of Thiamine, Ascorbic Acid, and the Combination of Them on the Levels of Matrix Metalloproteinase-9 in Sepsis Patients</title><source>DOAJ Directory of Open Access Journals</source><source>Dove Press Free</source><source>PubMed Central Open Access</source><source>Access via Taylor & Francis (Open Access Collection)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Lubis, Bastian ; Lelo, Aznan ; Amelia, Putri ; Prima, Agus</creator><creatorcontrib>Lubis, Bastian ; Lelo, Aznan ; Amelia, Putri ; Prima, Agus</creatorcontrib><description>Background: Sepsis is a global health problem. Therapeutic agents continue to develop for the management of sepsis. Ascorbic acid and thiamine are currently potential agents intensively studied for their benefits in sepsis. Methods: This study was a randomized controlled trial (RCT) with a pretest-posttest control group design. Randomization was using a computer. The research was conducted at Haji Adam Malik General Hospital Medan and Grand Medistra Hospital. Blood tests were at the Integrated Laboratory of the Faculty of Medicine, University of North Sumatra. The research was for 14 months. The number of patients in this study was 86 septic patients divided into four groups (NaCl, thiamine, ascorbic acid, and combination). The parameters measured were the enzyme MMP-9 and the enzyme TIMP-1. Results: The number of subjects who met the inclusion criteria was 147 patients. Fifty-three patients passed away during the monitoring period, and eight blood samples were damaged. The final data analyzed consisted of 86 subjects. Of the 86 septic patients obtained Based on initial MMP-9 values, MMP-9 levels increased in the 0.9% NaCl group (25.6%), while MMP-9 levels decreased after intervention in the thiamine, ascorbic acid, and combination groups but a significant decrease in MMP-9 was found in the ascorbic acid group (17.2%; p = 0.04) and the combination group (17.9%; p = 0.026). For TIMP-1 levels, a decreasing trend was only in the ascorbic acid (5.1%) and combination (5.9%) but not significant (p > 0.05). The highest MMP-9/TIMP-1 ratio was in septic patients receiving thiamine with a significant linear correlation (p < 0.05) between levels of MMP-9 and the MMP-9/TIMP-1 ratio with a moderate correlation level and significant negative correlation (p < 0.05) between TIMP-1 and the MMP-9/TIMP-1 with a moderate level of correlation. Conclusion: Administration of thiamine alone gives better advantages than ascorbic acid alone and their combination. Keywords: sepsis, MMP-9, TIMP-1, MMP-9/TIMP-1 ratio, thiamine, ascorbic acid</description><identifier>ISSN: 1178-6973</identifier><identifier>EISSN: 1178-6973</identifier><identifier>DOI: 10.2147/IDR.S378523</identifier><language>eng</language><publisher>Dove Medical Press Limited</publisher><subject>Blood ; Health aspects ; Infection ; Medical examination ; Medical research ; Medicine, Experimental ; Pyrimidines ; Vitamin C ; World health</subject><ispartof>Infection and drug resistance, 2022-10, Vol.15, p.5741</ispartof><rights>COPYRIGHT 2022 Dove Medical Press Limited</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,27924,27925</link.rule.ids></links><search><creatorcontrib>Lubis, Bastian</creatorcontrib><creatorcontrib>Lelo, Aznan</creatorcontrib><creatorcontrib>Amelia, Putri</creatorcontrib><creatorcontrib>Prima, Agus</creatorcontrib><title>The Effect of Thiamine, Ascorbic Acid, and the Combination of Them on the Levels of Matrix Metalloproteinase-9 in Sepsis Patients</title><title>Infection and drug resistance</title><description>Background: Sepsis is a global health problem. Therapeutic agents continue to develop for the management of sepsis. Ascorbic acid and thiamine are currently potential agents intensively studied for their benefits in sepsis. Methods: This study was a randomized controlled trial (RCT) with a pretest-posttest control group design. Randomization was using a computer. The research was conducted at Haji Adam Malik General Hospital Medan and Grand Medistra Hospital. Blood tests were at the Integrated Laboratory of the Faculty of Medicine, University of North Sumatra. The research was for 14 months. The number of patients in this study was 86 septic patients divided into four groups (NaCl, thiamine, ascorbic acid, and combination). The parameters measured were the enzyme MMP-9 and the enzyme TIMP-1. Results: The number of subjects who met the inclusion criteria was 147 patients. Fifty-three patients passed away during the monitoring period, and eight blood samples were damaged. The final data analyzed consisted of 86 subjects. Of the 86 septic patients obtained Based on initial MMP-9 values, MMP-9 levels increased in the 0.9% NaCl group (25.6%), while MMP-9 levels decreased after intervention in the thiamine, ascorbic acid, and combination groups but a significant decrease in MMP-9 was found in the ascorbic acid group (17.2%; p = 0.04) and the combination group (17.9%; p = 0.026). For TIMP-1 levels, a decreasing trend was only in the ascorbic acid (5.1%) and combination (5.9%) but not significant (p > 0.05). The highest MMP-9/TIMP-1 ratio was in septic patients receiving thiamine with a significant linear correlation (p < 0.05) between levels of MMP-9 and the MMP-9/TIMP-1 ratio with a moderate correlation level and significant negative correlation (p < 0.05) between TIMP-1 and the MMP-9/TIMP-1 with a moderate level of correlation. Conclusion: Administration of thiamine alone gives better advantages than ascorbic acid alone and their combination. Keywords: sepsis, MMP-9, TIMP-1, MMP-9/TIMP-1 ratio, thiamine, ascorbic acid</description><subject>Blood</subject><subject>Health aspects</subject><subject>Infection</subject><subject>Medical examination</subject><subject>Medical research</subject><subject>Medicine, Experimental</subject><subject>Pyrimidines</subject><subject>Vitamin C</subject><subject>World health</subject><issn>1178-6973</issn><issn>1178-6973</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNptjE9Lw0AQxRdRsNSe_AILXpuYbJL9cwy1aqFFsbmXzWa2XUl2S3YRr35zt9RDD84MzOPN7w1C93mWkrxkj6unj3RbMF6R4gpN8pzxhApWXF_oWzTz_jOLVQhaMjJBP80B8FJrUAE7jZuDkYOxMMe1V25sjcK1Mt0cS9vhENGFG1pjZTDOnnkYcJSn0xq-oPcndyPDaL7xBoLse3ccXYCY8ZAIbCzewtEbj9_jE7DB36EbLXsPs789Rc3zslm8Juu3l9WiXid7ysqEFpwLksuqYjrjgouO0Yoo2lY6DqOsY5xwqDKhoNBU5ioXpCVt1XaZFFwVU_RwfruXPeyM1S6MUg3Gq13NCOOMl6SMVPoPFbuDwShnQZvoXwR-Adskb_s</recordid><startdate>20221031</startdate><enddate>20221031</enddate><creator>Lubis, Bastian</creator><creator>Lelo, Aznan</creator><creator>Amelia, Putri</creator><creator>Prima, Agus</creator><general>Dove Medical Press Limited</general><scope/></search><sort><creationdate>20221031</creationdate><title>The Effect of Thiamine, Ascorbic Acid, and the Combination of Them on the Levels of Matrix Metalloproteinase-9 in Sepsis Patients</title><author>Lubis, Bastian ; Lelo, Aznan ; Amelia, Putri ; Prima, Agus</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g674-6388921a557f08989d7652c6b5fb5f767d7828e509ce3f6a1c192b2b5bd0a98c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Blood</topic><topic>Health aspects</topic><topic>Infection</topic><topic>Medical examination</topic><topic>Medical research</topic><topic>Medicine, Experimental</topic><topic>Pyrimidines</topic><topic>Vitamin C</topic><topic>World health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lubis, Bastian</creatorcontrib><creatorcontrib>Lelo, Aznan</creatorcontrib><creatorcontrib>Amelia, Putri</creatorcontrib><creatorcontrib>Prima, Agus</creatorcontrib><jtitle>Infection and drug resistance</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lubis, Bastian</au><au>Lelo, Aznan</au><au>Amelia, Putri</au><au>Prima, Agus</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Effect of Thiamine, Ascorbic Acid, and the Combination of Them on the Levels of Matrix Metalloproteinase-9 in Sepsis Patients</atitle><jtitle>Infection and drug resistance</jtitle><date>2022-10-31</date><risdate>2022</risdate><volume>15</volume><spage>5741</spage><pages>5741-</pages><issn>1178-6973</issn><eissn>1178-6973</eissn><abstract>Background: Sepsis is a global health problem. Therapeutic agents continue to develop for the management of sepsis. Ascorbic acid and thiamine are currently potential agents intensively studied for their benefits in sepsis. Methods: This study was a randomized controlled trial (RCT) with a pretest-posttest control group design. Randomization was using a computer. The research was conducted at Haji Adam Malik General Hospital Medan and Grand Medistra Hospital. Blood tests were at the Integrated Laboratory of the Faculty of Medicine, University of North Sumatra. The research was for 14 months. The number of patients in this study was 86 septic patients divided into four groups (NaCl, thiamine, ascorbic acid, and combination). The parameters measured were the enzyme MMP-9 and the enzyme TIMP-1. Results: The number of subjects who met the inclusion criteria was 147 patients. Fifty-three patients passed away during the monitoring period, and eight blood samples were damaged. The final data analyzed consisted of 86 subjects. Of the 86 septic patients obtained Based on initial MMP-9 values, MMP-9 levels increased in the 0.9% NaCl group (25.6%), while MMP-9 levels decreased after intervention in the thiamine, ascorbic acid, and combination groups but a significant decrease in MMP-9 was found in the ascorbic acid group (17.2%; p = 0.04) and the combination group (17.9%; p = 0.026). For TIMP-1 levels, a decreasing trend was only in the ascorbic acid (5.1%) and combination (5.9%) but not significant (p > 0.05). The highest MMP-9/TIMP-1 ratio was in septic patients receiving thiamine with a significant linear correlation (p < 0.05) between levels of MMP-9 and the MMP-9/TIMP-1 ratio with a moderate correlation level and significant negative correlation (p < 0.05) between TIMP-1 and the MMP-9/TIMP-1 with a moderate level of correlation. Conclusion: Administration of thiamine alone gives better advantages than ascorbic acid alone and their combination. Keywords: sepsis, MMP-9, TIMP-1, MMP-9/TIMP-1 ratio, thiamine, ascorbic acid</abstract><pub>Dove Medical Press Limited</pub><doi>10.2147/IDR.S378523</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1178-6973 |
ispartof | Infection and drug resistance, 2022-10, Vol.15, p.5741 |
issn | 1178-6973 1178-6973 |
language | eng |
recordid | cdi_gale_infotracmisc_A727878424 |
source | DOAJ Directory of Open Access Journals; Dove Press Free; PubMed Central Open Access; Access via Taylor & Francis (Open Access Collection); EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Blood Health aspects Infection Medical examination Medical research Medicine, Experimental Pyrimidines Vitamin C World health |
title | The Effect of Thiamine, Ascorbic Acid, and the Combination of Them on the Levels of Matrix Metalloproteinase-9 in Sepsis Patients |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T10%3A30%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Effect%20of%20Thiamine,%20Ascorbic%20Acid,%20and%20the%20Combination%20of%20Them%20on%20the%20Levels%20of%20Matrix%20Metalloproteinase-9%20in%20Sepsis%20Patients&rft.jtitle=Infection%20and%20drug%20resistance&rft.au=Lubis,%20Bastian&rft.date=2022-10-31&rft.volume=15&rft.spage=5741&rft.pages=5741-&rft.issn=1178-6973&rft.eissn=1178-6973&rft_id=info:doi/10.2147/IDR.S378523&rft_dat=%3Cgale%3EA727878424%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A727878424&rfr_iscdi=true |